1、 Product introduction
Chinese Name | English Name | Declaration Type | Department | Reportable Dosage Form | Declaration Progress | Strength | CAS |
拉莫三嗪 | Lamotrigine | 5+4 | Psychiatry Department | Tablet
| Already accepted | 25mg、50mg、100mg | 84057-84-1 |
【Indication】
Antiepileptic.
【Reportable Dosage Form &Strength】
Tablet :25mg、50mg、100mg
【Mechanism of Action】
Phenyltriazines are voltage sensitive sodium channel blockers. The mechanism of action may be to inhibit the release of excitatory amino acids - glutamate and aspartic acid in the brain and produce antiepileptic effect.
【Development Progress】
Already accepted
2、Domestic Declaration
Declaration Type | Reportable Dosage Form | Number of Declared Preparations | Number of Existing Preparation Enterprises |
5+4 | 片剂 | Total:10 domestic | 3 imported ,1 domestic |
![Brinzolamide 布林佐胺 CAS号:138890-62-7 Brinzolamide 布林佐胺 CAS号:138890-62-7]()
Guangzhou Tosun Pharmaceutical Ltd
FL 4-5,No.3, 2nd Kehui street, Science Park, Guangzhou High-tech Industrial Development Zone, Guangzhou, China. 510663
Tel: +86-20-66392416; Fax: +86-20-66392525